In all, 10 cases of invasive ductal breast carcinoma of no special type and one case of invasive secretory carcinoma of the breast were retrieved from the files of the Royal Marsden Hospital, with ...
MINNEAPOLIS, April 27, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope™ technology with ...
Relapsing low-grade glioma treated with bevacizumab and irinotecan as third-line therapy. Background: In the CNSOT, allelic losses on the arms of chromosomes 1p and 19q are not only a marker for ...
Precision Cancer Pathology group performs RNA in situ hybridization for formalin fixed paraffin embedded tissue sections, fixed cultured cells and fixed/frozen tissue sections. We use either ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of a range of new probes for in situ hybridization, a technique used in pathology laboratories to ...
Correlation of markers of oxidative damage and circulating IL6 levels with survival following treatment with bevacizumab in metastatic colorectal cancer patients. Improved techniques to localize foci ...
Advanced Cell Diagnostics Inc. (ACD), a leader in the field of molecular pathology and developer of cell and tissue-based analysis tools, has announced that its RNAscope ® RNA in situ hybridization ...
The In Situ Hybridization Market is global sales of US$ 1.4 billion in 2022, according to a recently published Future Market Insights business analysis report. By 2032, the market is anticipated to ...
The development of many different chromogens for light microscopy gives us the opportunity to explore different usage of multiplex immunohistochemistry (IHC) for clinical diagnostic purposes as well ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results